IP Verse

Sclerostin Binding Agents

Patent No. EP3670528 (titled "Sclerostin Binding Agents") was filed by Amgen on Apr 28, 2006. The application was issued on Sep 8, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JAMES POOLEJun 7, 2022CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3670528

AMGEN
Application Number
EP19211623A
Filing Date
Apr 28, 2006
Status
Granted And Under Opposition
Aug 6, 2021
Publication Date
Sep 8, 2021
External Links
Slate, Register , Google Patents